Market Cap (In SEK)
113.68 Million
Revenue (In SEK)
4.44 Million
Net Income (In SEK)
-229.36 Million
Avg. Volume
212.66 Thousand
- Currency
- SEK
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.9-5.6
- PE
- -
- EPS
- -
- Beta Value
- 1.016
- ISIN
- SE0011527845
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Mr. Stuart Gander
- Employee Count
- -
- Website
- https://www.qlinea.com
- Ipo Date
- 2018-12-07
- Details
- Q-linea AB (publ) engages in the development of instruments and consumables for infection diagnostics in Sweden. It offers inventive systems for in vitro diagnostics systems for infectious diseases. The company's lead product candidate is ASTar, an antibiotic susceptibility testing system used for positive blood cultures. It develops and delivers solutions for healthcare providers. Q-linea AB (publ) was incorporated in 2008 and is headquartered in Uppsala, Sweden.
More Stocks
-
NIVI-BNivika Fastigheter AB (publ)
NIVI-B
-
5151Hextar Global Berhad
5151
-
BEIA-BBeijer Alma AB (publ)
BEIA-B
-
SANGINITASanginita Chemicals Limited
SANGINITA
-
ZNZNFZinzino AB (publ)
ZNZNF
-
VISC
-
EXHI
-
CUB